Similar articles

• Assessing thyroid malignancy with double-phase scintigraphy using technetium-99m-MIBI.

  Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D, Vella A. Vattimo A, et al. J Nucl Med. 1998 Jan;39(1):215-6. J Nucl Med. 1998. PMID: 9443764 No abstract available.
• Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.

  Nakahara H, Noguchi S, Murakami N, Hoshi H, Jinnouchi S, Nagamachi S, Ohnishi T, Futami S, Flores LG 2nd, Watanabe K. Nakahara H, et al. J Nucl Med. 1996 Jun;37(6):901-4. J Nucl Med. 1996. PMID: 8683308
• Double-phase technetium-99m-sestamibi scanning to evaluate nodular thyroid malignancy.

  Alonso O, Mut F, Lago G. Alonso O, et al. J Nucl Med. 1996 Nov;37(11):1919-20. J Nucl Med. 1996. PMID: 8917213 No abstract available.
• Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.

  Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Scott AM, et al. J Nucl Med. 1992 Jul;33(7):1396-8. J Nucl Med. 1992. PMID: 1613584
• Detection of residual and recurrent thyroid cancer by radionuclide imaging.

  Maxon HR. Maxon HR. Thyroid. 1999 May;9(5):443-6. doi: 10.1089/thy.1999.9.443. Thyroid. 1999. PMID: 10365674 Review.